I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin

J L Whittingham, Y S Zhang, L Zakova, E J Dodson, J P Turkenburg, J Brange, G G Dodson

Research output: Contribution to journalArticlepeer-review

Abstract

Despentapeptide (des-B26-B30) insulin (DPI), an active modified insulin, has been crystallized in the presence of 20% acetic acid pH 2. A crystal structure analysis to 1.8 angstrom spacing (space group I222) revealed that the DPI molecule, which is unable to make beta-strand interactions for physio-logical dimer formation and is apparently monomeric in solution, formed an alternative lattice-generated dimer. The formation of this dimer involved interactions between surfaces which included the B9-B19 alpha-helices (usually buried by the dimer-dimer contacts within the native hexamer). The two crystallographically independent molecules within the dimer were essentially identical and were similar in conformation to T-state insulin as seen in the T-6 insulin hexamer. An unusual feature of each molecule in the dimer was the presence of two independent conformations at the B-chain C-terminus (residues B20-B25). Both conformations were different from that of native insulin, involving a 3.5 angstrom displacement of the B20-B23 beta-turn and a repositioning of residue PheB25 such that it made close van der Waals contact with the main body of the molecule, appearing to stabilize the B-chain C-terminus.

Original languageEnglish
Pages (from-to)505-511
Number of pages7
JournalActa crystallographica section d-Biological crystallography
Volume62
DOIs
Publication statusPublished - May 2006

Keywords

  • STRUCTURAL SWITCH
  • RECEPTOR-BINDING
  • SIDE-CHAIN
  • MAIN-CHAIN
  • PH
  • SPECTROSCOPY
  • REFINEMENT
  • RESOLUTION
  • RESIDUES
  • SOLVENT

Cite this